Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Withdrawn 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 41Lymphoma, B-Cell, Marginal Zone 22Lymphoma, Mantle-Cell 20Lymphoma, Follicular 18Lymphoma 17Lymphoma, Non-Hodgkin 15Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma, B-Cell 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Recurrence 8Burkitt Lymphoma 8Waldenstrom Macroglobulinemia 7Neoplasms 6Leukemia, Hairy Cell 4Leukemia, B-Cell 3Leukemia 3Hematologic Neoplasms 3beta-Thalassemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Heart Failure 2Epstein-Barr Virus Infections 2Dendritic Cell Sarcoma, Interdigitating 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Anemia, Refractory, with Excess of Blasts 2Thalassemia 1Sjogren's Syndrome 1

Interventions

Cyclophosphamide 7Biopsy 6fludarabine 5Specimen Handling 5Magnetic Resonance Spectroscopy 5ruxolitinib 3X-Rays 3Whole-Body Irradiation 3Vincristine 3Peripheral Blood Stem Cell Transplantation 3Cytarabine 310-propargyl-10-deazaaminopterin 3sodium-iodide symporter 2pembrolizumab 2cemiplimab 2Photons 2Methotrexate 2Ipilimumab 2Immunoglobulin G 2Hydrocortisone 2Etoposide 2Disulfides 2Dexamethasone 2Calcium Dobesilate 2CTLA-4 Antigen 2Azacitidine 2venetoclax 1tagraxofusp 1romidepsin 1nelarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, T-Cell × Rituximab × Clear all
NCT06756308 2026-04-07

A Study of Enasidenib in People With T-Cell Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
25 enrolled
Lymphoid

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡